DLRHX Holdings List

As of May 31, 2025

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	8.60%	76,000
2	BSX	Boston Scientific Corporation	6.14%	380,000
3	PFE	Pfizer Inc.	4.13%	1,145,000
4	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	4.04%	500,000
5	SWX: ROG	Roche Holding AG	3.71%	75,000
6	ABBV	AbbVie Inc.	3.71%	130,000
7	ELV	Elevance Health, Inc.	3.71%	63,000
8	MRK	Merck & Co., Inc.	3.65%	310,000
9	GILD	Gilead Sciences, Inc.	3.55%	210,000
10	AMGN	Amgen Inc.	3.54%	80,000
11	REGN	Regeneron Pharmaceuticals, Inc.	3.53%	47,000
12	UNH	UnitedHealth Group Incorporated	3.47%	75,000
13	EBR: UCB	UCB SA	3.12%	112,137
14	LON: AZN	AstraZeneca PLC	2.91%	131,243
15	EPA: SAN	Sanofi	2.52%	165,423
16	FNMA	Federal National Mortgage Association Fannie Mae	2.10%	1,300,000
17	HALO	Halozyme Therapeutics, Inc.	1.89%	220,000
18	VRTX	Vertex Pharmaceuticals Incorporated	1.70%	25,000
19	JNJ	Johnson & Johnson	1.67%	70,000
20	VTRS	Viatris Inc.	1.58%	1,170,018
21	QURE	uniQure N.V.	1.57%	706,166
22	ALKS	Alkermes plc	1.41%	300,000
23	ALNY	Alnylam Pharmaceuticals, Inc.	1.40%	30,000
24	VKTX	Viking Therapeutics, Inc.	1.36%	330,100
25	NBIX	Neurocrine Biosciences, Inc.	1.32%	70,000

As of May 31, 2025

Showing 25 of 108

Subscribe to see the full list

Asset Allocation

Asset Class	% Weight
Stocks	100.00%